See every side of every news story
Published loading...Updated

Phase 3 Findings on Roflumilast Foam 0.3% for Scalp and Body Psoriasis, with Jennifer Soung, MD

Summary by hcplive.com
This interview with Jennifer Soung, MD, highlights the implications of recent phase 3 findings on roflumilast foam 0.3% (Zoryve) for psoriasis of the scalp and body.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

hcplive.com broke the news in on Friday, May 16, 2025.
Sources are mostly out of (0)